Press Releases
Press Releases
-
February 10, 2020
U.S. FDA Grants Priority Review for Kite’s KTE-X19 Biologics License Application (BLA) in Relapsed or Refractory Mantle Cell Lymphoma -
February 4, 2020
Gilead Sciences Announces 8 Percent Increase In First Quarter 2020 Dividend -
February 4, 2020
Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results -
January 30, 2020
Sandra Horning, MD, Joins Gilead Sciences’ Board of Directors -
January 28, 2020
European Medicines Agency Validates Kite’s Marketing Application for Company’s Second CAR T Cell Therapy -
January 21, 2020
Gilead Sciences to Release Fourth Quarter and Full Year 2019 Financial Results on Tuesday, February 4, 2020 -
January 9, 2020
Gilead Sciences Licenses Portfolio of HIV Antibodies From The Rockefeller University